SOLOFLOW
LIVE

Serial Number

79108116

Owner

SSB Technology Pty Ltd

Filing Date

Nov 28, 2011

Add to watchlist:

No watchlists yet
View on USPTO

SOLOFLOW Trademark

Serial Number: 79108116 • Registration: 4159778

SOLOFLOW is a trademark filed by SSB Technology Pty Ltd on November 28, 2011. The trademark is classified under Class 10 (Medical Apparatus). The application is currently registered and active.

Owner Contact Info

SSB Technology Pty Ltd (5 trademarks)

Caribbean Business Park
SCORESBY VIC 3179 , AU

Entity Type: 99

Trademark Details

Filing Date

November 28, 2011

Registration Date

June 19, 2012

Published for Opposition

April 3, 2012

Cancellation Date

November 28, 2021

Goods & Services

Disposable syringes; hypodermic syringes; medical syringes; injection syringes for medical purposes; disposable hypodermic syringes for medical use, disposable needles for hypodermic syringes; medical syringe needles: medicinal injection syringes; push syringes for medical use; syringes for injections, medical cannulae

Filing History

NOTIFICATION OF EFFECT OF CANCELLATION OF INTL REG MAILED
Jun 26, 2022 DENC
DEATH OF INTERNATIONAL REGISTRATION
Jun 26, 2022 DETH
TOTAL INVALIDATION PROCESSED BY THE IB
Oct 18, 2019 INNT
TOTAL INVALIDATION OF REG EXT PROTECTION SENT TO IB
Sep 30, 2019 INTS
INVALIDATION PROCESSED
Sep 30, 2019 INPC
TOTAL INVALIDATION OF REG EXT PROTECTION CREATED
Sep 25, 2019 INTR
CANCELLED SECTION 71
Jan 25, 2019 C71T
NOTIFICATION PROCESSED BY IB
Oct 6, 2012 GPNX
FINAL DISPOSITION NOTICE SENT TO IB
Sep 11, 2012 FICS
FINAL DISPOSITION PROCESSED
Sep 11, 2012 FIMP
GRANT OF PROTECTION CREATED, TO BE SENT TO IB
Jul 19, 2012 GPAR
REGISTERED-PRINCIPAL REGISTER
Jun 19, 2012 R.PR
PUBLISHED FOR OPPOSITION
Apr 3, 2012 PUBO
NOTICE OF PUBLICATION
Mar 14, 2012 NPUB
APPROVED FOR PUB - PRINCIPAL REGISTER
Feb 24, 2012 CNSA
ASSIGNED TO EXAMINER
Feb 23, 2012 DOCK
APPLICATION FILING RECEIPT MAILED
Feb 7, 2012 MAFR
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Feb 3, 2012 NWOS
SN ASSIGNED FOR SECT 66A APPL FROM IB
Feb 2, 2012 REPR